Hi-Tech Pharmacal Co. (HITK) acquired Licenses Rights from KVK-Tech for dexbrompheniramine and pseudoephedrine- Lodrane
Posted on August 25, 2011 at 08:39 AM EDT
Hi-Tech Pharmacal Co. (NASDAQ: HITK), a specialty manufacturer and marketer of prescription, over-the-counter (OTC) and nutritional products, announced that they have acquired marketing and distribution rights to an ANDA filing from KVK-Tech, Inc., industry-leading developer, manufacturer and... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here